RC118 is an antibody-drug conjugate that consists of a recombinant humanized IgG1 anti-Claudin18.2 monoclonal antibody conjugated to MMAE.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.